BLADX
Price
$9.74
Change
-$0.00 (-0.00%)
Updated
Oct 8 closing price
Net Assets
836.01M
BLDRX
Price
$9.76
Change
-$0.00 (-0.00%)
Updated
Oct 8 closing price
Net Assets
836.01M
Interact to see
Advertisement

BLADX vs BLDRX

Header iconBLADX vs BLDRX Comparison
Open Charts BLADX vs BLDRXBanner chart's image
BlackRock Managed Income Investor A
Price$9.74
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets836.01M
BlackRock Managed Income K
Price$9.76
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets836.01M
BLADX vs BLDRX Comparison Chart in %
View a ticker or compare two or three
VS
BLADX vs. BLDRX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLADX is a Buy and BLDRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BLADX (836M) and BLDRX (836M) have equal amount of cash in the bank . BLDRX pays higher dividends than BLADX: BLDRX (5.67) vs BLADX (5.37). BLADX was incepted earlier than BLDRX: BLADX (18 years) vs BLDRX (18 years). BLADX (0.94) is less costly to investors than BLDRX (0.64). BLADX (80.00) and BLDRX (80.00) have comparable annual turnover. BLADX has a lower initial minimum investment than BLDRX: BLADX (1000) vs BLDRX (5000000). BLDRX (7.19) and BLADX (6.88) have marching annual gain over last year. BLDRX return over 5 years is better than : 22.62 vs. BLADX (20.78).
BLADXBLDRXBLADX / BLDRX
Total Expense Ratio0.720.42171%
Annual Report Gross Expense Ratio0.940.64147%
Fund Existence18 years18 years-
Gain YTD8.3168.43199%
Front Load4%N/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets836M836M100%
Annual Yield % from dividends5.375.6795%
Returns for 1 year6.887.1996%
Returns for 3 years29.4530.6096%
Returns for 5 years20.7822.6292%
Returns for 10 years48.1852.8191%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNPX0.240.04
+20.76%
Genprex
SMMT23.341.05
+4.71%
Summit Therapeutics
PAGS9.340.37
+4.12%
PagSeguro Digital Ltd
TCRX1.980.01
+0.51%
TScan Therapeutics
MAX10.81-0.40
-3.57%
MediaAlpha